Back
Perspective Therapeutics Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
30
CATX
Perspective Therapeutics
Last Price:
3.07
Seasonality Move:
34.33%
7 Day Trial
ALL ACCESS PASS
$
7
Access The Stock Grader Trading Tool From "The King Of Quants"
More details here...- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.
Perspective Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.55 | Sell |
| 20-day SMA: | 10.54 | Sell |
| 50-day SMA: | 12.08 | Sell |
| 200-day SMA: | 12.78 | Sell |
| 8-day EMA: | 8.2 | Sell |
| 20-day EMA: | 9.96 | Sell |
| 50-day EMA: | 11.52 | Sell |
| 200-day EMA: | 11.52 | Sell |
Perspective Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.47 | Sell |
| Relative Strength Index (14 RSI): | 14.63 | Sell |
| Chaikin Money Flow: | -723713 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.98 - 12.88) | Sell |
| Bollinger Bands (100): | (10.81 - 14.53) | Sell |
Perspective Therapeutics Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Perspective Therapeutics Stock
Is Perspective Therapeutics Stock a Buy?
- Perspective Therapeutics share price is 6.17 while CATX 8-day simple moving average is 8.55, which is a Sell signal.
- The stock price of CATX is 6.17 while Perspective Therapeutics 20-day SMA is 10.54, which makes it a Sell.
- Perspective Therapeutics 50-day simple moving average is 12.08 while CATX share price is 6.17, making it a Sell technically.
- CATX stock price is 6.17 and Perspective Therapeutics 200-day simple moving average is 12.78, creating a Sell signal.
CATX Technical Analysis vs Fundamental Analysis
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy or a Sell?
-
Perspective Therapeutics stock is rated a Sell
The current Perspective Therapeutics [CATX] share price is $6.17. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
Perspective Therapeutics Stock Info
Market Cap:
417.01M
Price in USD:
6.17
Share Volume:
1.16M
Perspective Therapeutics 52-Week Range
52-Week High:
19.05
52-Week Low:
2.28
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Perspective Therapeutics Share Price Forecast
-
What is the Perspective Therapeutics stock price today?
The Perspective Therapeutics stock price is 6.17 USD today. -
Will CATX stock go up or go down?
Perspective Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Perspective Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Perspective Therapeutics is overvalued.
Is Perspective Therapeutics Stock a Buy?
- Perspective Therapeutics share price is 6.17 while CATX 8-day exponential moving average is 8.20, which is a Sell signal.
- The stock price of CATX is 6.17 while Perspective Therapeutics 20-day EMA is 9.96, which makes it a Sell.
- Perspective Therapeutics 50-day exponential moving average is 11.52 while CATX share price is 6.17, making it a Sell technically.
- CATX stock price is 6.17 and Perspective Therapeutics 200-day simple moving average is 11.52, creating a Sell signal.
Fundamental Analysis of Perspective Therapeutics
Is Perspective Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.
Technical Analysis of Perspective Therapeutics
Should I short Perspective Therapeutics stock?
- CATX Moving Average Covergence Divergence (MACD) indicator is -1.47, suggesting Perspective Therapeutics is a Sell
- Perspective Therapeutics Relative Strength Index (RSI) is 14.63, which suggest Perspective Therapeutics is oversold
- The Bollinger Bands (25) for Perspective Therapeutics is (8.98 - 12.88), which suggest Perspective Therapeutics is a Sell
- The Bollinger Bands (100) for Perspective Therapeutics is (10.81 - 14.53), which suggest Perspective Therapeutics is a Sell
* Perspective Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.